Work

Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).

Year: 1996

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1016/s0022-3565(25)21285-x

Authors: Q Li, I Murakami, S Stall, A D Levy, M S Brownfield, D E Nichols, L D Van de Kar

Institutions: Loyola University Chicago, University of Wisconsin–Madison, Purdue University West Lafayette

Language: English

Topic: Neurotransmitter Receptor Influence on Behavior

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Neurological Disorders and Stroke

Awards: VASOPRESSIN AS A NEUROENDOCRINE MARKER IN DEPRESSION, G2802304139, EFFECTS OF COCAINE ON NEUROENDOCRINE FUNCTION, G474073316, G5195821315

OpenAlex ID: W1929502434

FWCI: 0.405

Cites:

Cited by: 24

Related to: 10